Excessive Daytime Somnolence

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-04-16
Clinical Trial Update: Caffeine for Excessive Daytime Somnolence in Parkinson's Disease [Phase 2, Phase 3]
Phase 2/3 trials studied caffeine for Excessive daytime somnolence in Parkinson's disease. The trial status is completed.